Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 7, 2010
[The inhibitory effects at the α-strain of insulin-like growth factor 1 receptor on SPCA-1 and A549 lung adenocarcinoma cell lines]Zongyang Yu, Jian Du, Xuenong Ouyang, et al.
Pathology, Research and Practice|February 12, 2022
Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinomaYing Chen, Wencui Kong, Zongyang Yu, et al.
Oncotargets and Therapy|December 28, 2018
Next-generation sequencing of circulating tumor DNA for detection of gene mutations in lung cancer: implications for precision treatmentJinhuo Lai, Bin Du, Yao Wang, et al.
Translational Cancer Research|February 4, 2022
Pazopanib as salvage therapy in metastatic renal cell carcinoma with hypercalcemic crisis and renal insufficiency: a case report and literature reviewYing Chen, Xiaoming Ling, Wencui Kong, et al.
Thoracic Cancer|November 18, 2024
USP8-mediated PTK7 promotes PIK3CB-related pathway to accelerate the malignant progression of non-small cell lung cancerWencui Kong, Xuegang Feng, Zongyang Yu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 18, 2022
Cancer cell-derived exosomal LINC00313 induces M2 macrophage differentiation in non-small cell lung cancerWencui Kong, Lei Zhang, Ying Chen, et al.
Frontiers in Oncology|January 4, 2021
Response of Metastatic Chordoma to the Immune Checkpoint Inhibitor Pembrolizumab: A Case ReportXiaoli Wu, Xiangwu Lin, Ying Chen, et al.
Biochemical and Biophysical Research Communications|August 17, 2025
CPT1A promotes the proliferation and immune evasion of lung cancer by inducing CTLA-4 K154 succinylationWencui Kong, Jingrong Yang, Xingfeng Qi, et al.
Peerj|November 18, 2024
Comprehensive analysis of transcriptomics and radiomics revealed the potential of TEDC2 as a diagnostic marker for lung adenocarcinomaQian Huang, Peng Zhang, Zhixu Guo, et al.
Frontiers in Oncology|February 28, 2022
Outcomes in Patients With Lung Adenocarcinoma With Transformation to Small Cell Lung Cancer After EGFR Tyrosine Kinase Inhibitors Resistance: A Systematic Review and Pooled AnalysisJinhe Xu, Lihuan Xu, Baoshan Wang, et al.
Pageof 8